17-methylene-androstan-3alpha-ol analogs as crh inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/568 (2006.01) A61K 31/565 (2006.01) A61K 31/5685 (2006.01) A61K 31/57 (2006.01)

Patent

CA 2484596

17-Methylene-androstan-3.alpha.-ol analogs are useful as corticotropin releasing hormone (CRH) inhibitors, and especially as anti-depressants, when administered to the vomeronasal organ. An improved synthesis of 17- methyleneandrost-4-en-3.alpha.-ol is disclosed.

L'invention concerne des analogues de 17-méthylène-androstan-3.alpha.-ol pouvant servir d'inhibiteurs de l'hormone de libération de la corticotrophine (CRH), et plus particulièrement, d'antidépresseurs lorsqu'ils sont administrés à l'organe voméro-nasal. L'invention concerne en outre une synthèse améliorée de 17-méthylèneandrost-3.alpha.-ol.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

17-methylene-androstan-3alpha-ol analogs as crh inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 17-methylene-androstan-3alpha-ol analogs as crh inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17-methylene-androstan-3alpha-ol analogs as crh inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1772759

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.